H P Chase

Summary

Affiliation: University of Colorado Health Sciences Center
Country: USA

Publications

  1. ncbi Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with type 1 diabetes
    H P Chase
    Department of Paediatrics, Barbara Davis Center, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Diabet Med 19:317-21. 2002
  2. ncbi Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes
    Erin Cobry
    Barbara Davis Center for Childhood Diabetes, Aurora, Colorado 80045, USA
    Diabetes Technol Ther 12:173-7. 2010
  3. ncbi Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin
    H Peter Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Science Center, Denver, Colorado, USA
    J Pediatr 143:737-40. 2003
  4. ncbi Elevated C-reactive protein levels in the development of type 1 diabetes
    H Peter Chase
    Department of Pediatrics, The Barbara Davis Center for Childhood Diabetes, Denver, Colorado, USA
    Diabetes 53:2569-73. 2004
  5. ncbi The use of insulin pumps with meal bolus alarms in children with type 1 diabetes to improve glycemic control
    H Peter Chase
    Department of Pediatrics, University of Colorado Health Sciences Center, Barbara Davis Center for Childhood Diabetes, Mail Stop A140, P O Box 6511, Aurora, CO 80045 6511, USA
    Diabetes Care 29:1012-5. 2006
  6. ncbi Insulin glargine versus intermediate-acting insulin as the basal component of multiple daily injection regimens for adolescents with type 1 diabetes mellitus
    H Peter Chase
    Barbara Davis Center, University of Colorado, Aurora, CO 80045 6511, USA
    J Pediatr 153:547-53. 2008
  7. ncbi Modem transmission of glucose values reduces the costs and need for clinic visits
    H Peter Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, USA
    Diabetes Care 26:1475-9. 2003
  8. ncbi Redefining the clinical remission period in children with type 1 diabetes
    H Peter Chase
    University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Pediatr Diabetes 5:16-9. 2004
  9. ncbi Continuous subcutaneous glucose monitoring in children with type 1 diabetes
    H P Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, Denver, Colorado 80262, USA
    Pediatrics 107:222-6. 2001
  10. ncbi The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes
    H P Chase
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, USA
    Diabetes Care 24:430-4. 2001

Research Grants

  1. Glucose Sensors in Children with Type I Diabetes
    H Chase; Fiscal Year: 2006

Collaborators

Detail Information

Publications59

  1. ncbi Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with type 1 diabetes
    H P Chase
    Department of Paediatrics, Barbara Davis Center, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Diabet Med 19:317-21. 2002
    ..To determine if one method of short-acting insulin bolus administration is superior to other methods in managing a meal high in carbohydrates, calories and fat...
  2. ncbi Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes
    Erin Cobry
    Barbara Davis Center for Childhood Diabetes, Aurora, Colorado 80045, USA
    Diabetes Technol Ther 12:173-7. 2010
    ..This study determined the optimal timing of insulin bolus administration in relation to meal consumption in adolescents and adults with type 1 diabetes...
  3. ncbi Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin
    H Peter Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Science Center, Denver, Colorado, USA
    J Pediatr 143:737-40. 2003
    ..The numbers of nonsevere and severe hypoglycemic events, hemoglobin A1c values, body weight, and daily insulin dose were recorded at each clinic visit...
  4. ncbi Elevated C-reactive protein levels in the development of type 1 diabetes
    H Peter Chase
    Department of Pediatrics, The Barbara Davis Center for Childhood Diabetes, Denver, Colorado, USA
    Diabetes 53:2569-73. 2004
    ..The elevated CRP levels may provide an additional marker for risk of progression to type 1 diabetes...
  5. ncbi The use of insulin pumps with meal bolus alarms in children with type 1 diabetes to improve glycemic control
    H Peter Chase
    Department of Pediatrics, University of Colorado Health Sciences Center, Barbara Davis Center for Childhood Diabetes, Mail Stop A140, P O Box 6511, Aurora, CO 80045 6511, USA
    Diabetes Care 29:1012-5. 2006
    ..The aim of this study was to determine whether the use of meal bolus alarms would result in fewer missed meal boluses per week in youth with type 1 diabetes using continuous subcutaneous insulin infusion (CSII) therapy...
  6. ncbi Insulin glargine versus intermediate-acting insulin as the basal component of multiple daily injection regimens for adolescents with type 1 diabetes mellitus
    H Peter Chase
    Barbara Davis Center, University of Colorado, Aurora, CO 80045 6511, USA
    J Pediatr 153:547-53. 2008
    ....
  7. ncbi Modem transmission of glucose values reduces the costs and need for clinic visits
    H Peter Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, USA
    Diabetes Care 26:1475-9. 2003
    ..To determine whether modem technology allows for effective management of type 1 diabetes when used in lieu of a clinic visit...
  8. ncbi Redefining the clinical remission period in children with type 1 diabetes
    H Peter Chase
    University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Pediatr Diabetes 5:16-9. 2004
    ..To redefine the clinical remission period for different aged children receiving the current standard of diabetes care...
  9. ncbi Continuous subcutaneous glucose monitoring in children with type 1 diabetes
    H P Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, Denver, Colorado 80262, USA
    Pediatrics 107:222-6. 2001
    ....
  10. ncbi The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes
    H P Chase
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, USA
    Diabetes Care 24:430-4. 2001
    ....
  11. ncbi Long-term efficacy of humalog in subjects with Type 1 diabetes mellitus
    S K Garg
    Barbara Davis Center for Childhood Diabetes, Department of Paediatrics, University of Colorado Health Sciences Center, Denver, USA
    Diabet Med 16:384-7. 1999
    ..To evaluate the long-term effectiveness of Humalog insulin in lowering post meal glucose excursions...
  12. ncbi Use of the GlucoWatch biographer in children with type 1 diabetes
    H Peter Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado, USA
    Pediatrics 111:790-4. 2003
    ..The use of the biographer with an alarm to detect nocturnal hypoglycemia has the potential to increase the safety of diabetes management in children...
  13. ncbi Improved glycemic control after long-term insulin pump use in pediatric patients with type 1 diabetes
    Laura Scrimgeour
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, CO 80045, USA
    Diabetes Technol Ther 9:421-8. 2007
    ..There are currently few data available on the long-term use of continuous subcutaneous insulin infusion (CSII) (insulin pump) therapy in children...
  14. ncbi Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care
    A K Maniatis
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Pediatrics 107:351-6. 2001
    ..CONCLUSIONS: CSII therapy is an appropriate option for some children in routine pediatric diabetes care. It can effectively decrease the HbA(1c) and reduce hypoglycemic episodes, without producing an abnormal increase in BMI...
  15. ncbi Use of a subcutaneous injection port to improve glycemic control in children with type 1 diabetes
    Patricia Burdick
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, CO, USA
    Pediatr Diabetes 10:116-9. 2009
    ..To determine if use of an injection port, the Insuflon, would help to improve glycemic control in youth with type 1 diabetes (TID) who were in suboptimal glycemic control (hemoglobin A1c, HbA1c >8.0%)...
  16. ncbi Missed insulin boluses for snacks in youth with type 1 diabetes
    Brandon W Vanderwel
    University of Colorado, Aurora, Colorado, USA
    Diabetes Care 33:507-8. 2010
    ..3 vs. 1.1 mg/dl per minute; P < 0.001). CONCLUSIONS This study shows that afternoon snacks without insulin boluses are common and result in significantly higher glucose excursions than snacks with insulin administration...
  17. ncbi Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset
    Taylor M Triolo
    University of Colorado Denver, Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, USA
    Diabetes Care 32:769-73. 2009
    ..Metabolic tests and the presence of symptoms were described at diabetes onset during the Diabetes Prevention Trial-Type 1 (DPT-1)...
  18. ncbi A pilot trial of pramlintide home usage in adolescents with type 1 diabetes
    Christopher M Kishiyama
    Department of Pediatrics, University of Colorado, Aurora, Colorado 80045, USA
    Pediatrics 124:1344-7. 2009
    ..The objective of this study was to evaluate the safety and efficacy of home pramlintide use in adolescents with type 1 diabetes...
  19. ncbi Continuous glucose monitoring in youth with type 1 diabetes
    R Paul Wadwa
    Barbara Davis Center for Childhood Diabetes, Aurora, Colorado 80045, USA
    Diabetes Technol Ther 11:S83-91. 2009
    ..In the future, CGM use in youth may couple with insulin pump technology to create a "closed-loop" system in which the CGM device will direct insulin administration without user input...
  20. ncbi Factors affecting improved glycaemic control in youth using insulin pumps
    J Wilkinson
    University of Colorado, Aurora, CO, USA
    Diabet Med 27:1174-7. 2010
    ..The purpose of this study was to evaluate factors associated with insulin pump therapy resulting in lower HbA(1c) levels in young people with Type 1 diabetes mellitus...
  21. ncbi Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes
    S K Garg
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver 80262, USA
    Diabetes Care 22:1708-14. 1999
    ..Redwood City, CA) with capillary blood glucose values that were determined 1) in a controlled outpatient clinic setting and 2) in a home setting...
  22. ncbi Mixing rapid-acting insulin analogues with insulin glargine in children with type 1 diabetes mellitus
    Rosanna Fiallo-Scharer
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado, USA
    J Pediatr 148:481-4. 2006
    ..To determine whether mixing insulin glargine (IG) with a rapid-acting insulin (RAI) analogue in the same syringe had any deleterious effects on glycemic control in children with type 1 diabetes mellitus...
  23. ncbi Prevention strategies for type 1 diabetes
    Christopher M Kishiyama
    The Barbara Davis Center for Childhood Diabetes, Denver, CO, USA
    Rev Endocr Metab Disord 7:215-24. 2006
    ..This review article describes the past, current and upcoming strategies for diabetes prevention for patients at risk for developing autoimmunity, after antibody production, and patients with new onset diabetes...
  24. ncbi Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing
    Jennifer M Barker
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    J Pediatr 150:31-36.e6. 2007
    ....
  25. ncbi The role of continuous glucose sensors in diabetes care
    Satish K Garg
    Department of Medicine, University of Colorado Health Sciences Center, 4200 East 9th Avenue, Campus Box B-140, Denver, CO 80262, USA
    Endocrinol Metab Clin North Am 33:163-73, x-xi. 2004
  26. ncbi Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes
    Jill M Norris
    Department of Preventive Medicine and Biostatistics, University of Colorado at Denver and Health Sciences Center, Denver, CO 80262, USA
    JAMA 298:1420-8. 2007
    ..Cod liver oil supplements in infancy have been associated with a decreased risk of type 1 diabetes mellitus in a retrospective study...
  27. ncbi Use of CoZmonitor in youth with type 1 diabetes
    Erin Cobry
    Department of Pediatrics, Barbara Davis Center, University of Colorado Health Sciences Center, Aurora, CO 80045 6511, USA
    Pediatr Diabetes 9:148-51. 2008
    ..The purpose of this study was to evaluate the effectiveness of directly integrating self-monitoring blood glucose (BG) information with insulin pump therapy on overall glycemic control...
  28. ncbi The use of insulin pumps in youth with type 1 diabetes
    David M Maahs
    University of Colorado Barbara Davis Center for Childhood Diabetes, 1775 Aurora Court, Aurora, CO 80045, USA
    Diabetes Technol Ther 12:S59-65. 2010
    ..Finally, diabetes management in the 21st century, in which pump therapy is combined with continuous glucose monitoring, and its potential for a closed-loop pancreas are presented...
  29. ncbi Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy
    Jonathan Burdick
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado, USA
    Pediatrics 113:e221-4. 2004
    ..414) and mean blood glucose levels (r =.70). CONCLUSION: Missed mealtime insulin boluses seem to be the major cause of suboptimal glycemic control in youths with diabetes receiving continuous subcutaneous insulin infusion therapy...
  30. ncbi Glycemic parameters with multiple daily injections using insulin glargine versus insulin pump
    Satish K Garg
    Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Diabetes Technol Ther 6:9-15. 2004
    ..However, costs and episodes of diabetic ketoacidosis are significantly higher for insulin pump users...
  31. ncbi Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine
    Satish K Garg
    Department of Medicine, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Diabetes Res Clin Pract 66:49-56. 2004
    ..Sixty-three subjects were taking glargine in the morning, 125 were taking glargine in the evening, and 104 were splitting the glargine dose between the morning and evening...
  32. ncbi Continuous glucose monitoring in type 1 diabetes
    Stuart A Weinzimer
    Yale University School of Medicine, Department of Pediatrics, PO Box 208064, 333 Cedar Street, New Haven, CT 06520, USA
    Curr Diab Rep 4:95-100. 2004
    ..The current "state of the art" of this technology, including accuracy, performance in clinical trials, limitations, and recommendations for use, is discussed for the two currently approved continuous glucose monitoring devices...
  33. ncbi Inflammatory markers and diabetic retinopathy in type 1 diabetes
    Kenneth E Izuora
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 East 9th Ave, Box B-140, Denver, CO, USA
    Diabetes Care 28:714-5. 2005
  34. ncbi Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial
    H Peter Chase
    Barbara Davis Center, Denver, Colorado, USA
    Diabetes Technol Ther 12:507-15. 2010
    ..The use of continuous glucose monitoring (CGM) in the pediatric population is not well characterized. We have evaluated the use of CGM over a 12-month interval in youth with type 1 diabetes (TID) and have provided a description of CGM use...
  35. ncbi Predictors of acute complications in children with type 1 diabetes
    Arleta Rewers
    Pediatric Emergency Medicine, Department of Pediatrics, University of Colorado, School of Medicine, The Children s Hospital, Denver, CO 80218, USA
    JAMA 287:2511-8. 2002
    ..Diabetic ketoacidosis and severe hypoglycemia are acute complications of type 1 diabetes that are related, respectively, to insufficient or excessive insulin treatment. However, little is known about additional modifiable risk factors...
  36. ncbi Pramlintide lowered glucose excursions and was well-tolerated in adolescents with type 1 diabetes: results from a randomized, single-blind, placebo-controlled, crossover study
    H Peter Chase
    Barbara Davis Center for Childhood Diabetes, University of Colorado, Aurora, CO 80045 6511, USA
    J Pediatr 155:369-73. 2009
    ..To evaluate the pharmacokinetics, pharmacodynamics, safety, and tolerability of pramlintide in treating adolescents with type 1 diabetes...
  37. ncbi In utero dietary exposures and risk of islet autoimmunity in children
    Carolyn M Fronczak
    Department of Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, Colorado, USA
    Diabetes Care 26:3237-42. 2003
    ..CONCLUSIONS: Our findings suggest that maternal intake of vitamin D through food during pregnancy may have a protective effect on the appearance of IA in offspring...
  38. ncbi Don't take away my pump! Switching to injections may cause problems
    H Peter Chase
    University of Colorado Health Sciences Center, Denver, Colorado, USA
    Diabetes Forecast 58:55-6. 2005
  39. ncbi Preventing post-exercise nocturnal hypoglycemia in children with type 1 diabetes
    Craig E Taplin
    University of Colorado, Barbara Davis Center for Childhood Diabetes, Aurora, CO 80045, USA
    J Pediatr 157:784-8.e1. 2010
    ..To determine the effects of reducing overnight basal insulin or a bedtime dose of terbutaline on nocturnal blood glucose (BG) nadir and hypoglycemia after exercise in children with type 1 diabetes mellitus...
  40. ncbi First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes
    H P Chase
    Barbara Davis Center, University of Colorado Health Sciences Center, Denver, USA
    J Pediatr 138:244-9. 2001
    ..CONCLUSION: FPIR in the IV-GTT correlates strongly with risk factors for development of type 1 diabetes...
  41. ncbi Clinical trials for the prevention of type 1 diabetes
    H Peter Chase
    Barbara Davis Center for Childhood Diabetes, University of Colorado, Health Sciences Center, Denver, USA
    Adv Exp Med Biol 552:291-305. 2004
  42. ncbi Bedside monitoring of blood beta-hydroxybutyrate levels in the management of diabetic ketoacidosis in children
    Arleta Rewers
    Pediatric Emergency Medicine, Department of Pediatrics, University of Colorado at Denver and Health Sciences Center, Denver, Colorado 80218, USA
    Diabetes Technol Ther 8:671-6. 2006
    ..The purpose of this study was to evaluate if bedside monitoring of blood beta-OHB levels can simplify management of DKA through elimination of superfluous laboratory monitoring...
  43. ncbi Detection of ketosis and monitoring of diabetic ketoacidosis
    H Peter Chase
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, USA
    Manag Care 13:5-6; discussion 19-21. 2004
  44. ncbi Cost-effectiveness of use of the GlucoWatch Biographer in children and adolescents with type 1 diabetes: a preliminary analysis based on a randomized controlled trial
    Richard C Eastman
    Cygnus, Inc, 400 Penobscot Drive, Redwood City, California 94063, USA
    Pediatr Diabetes 4:82-6. 2003
    ..To conduct a preliminary analysis of the cost-effectiveness of the use of the GlucoWatch Biographer in the management of type 1 diabetes in children and adolescents...
  45. ncbi Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus
    Eva Tsalikian
    DirectNet Coordinating Center, Jaeb Center for Health Research, Tampa, Florida 33647, USA
    J Pediatr 147:528-34. 2005
    ..To examine the effect of exercise on overnight hypoglycemia in children with type 1 diabetes mellitus (T1DM)...
  46. ncbi JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods
    William V Tamborlane
    Diabetes Technol Ther 10:310-21. 2008
    ..RESULTS: Recruitment for the study was completed on December 15, 2007. CONCLUSION: Results of this clinical trial should help establish whether or not current RT-CGM devices are beneficial to patients with T1D...
  47. ncbi The accuracy of the Guardian RT continuous glucose monitor in children with type 1 diabetes
    Michael Tansey
    Diabetes Technol Ther 10:266-72. 2008
    ..The Guardian RT has an accuracy similar to that of other available continuous glucose monitors and can give important and useful clinical information...
  48. ncbi Continuous glucose monitoring and intensive treatment of type 1 diabetes
    William V Tamborlane
    N Engl J Med 359:1464-76. 2008
    ..Further work is needed to identify barriers to effectiveness of continuous monitoring in children and adolescents. (ClinicalTrials.gov number, NCT00406133.)..
  49. ncbi Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study
    Stuart A Weinzimer
    DirecNet Coordinating Center, Jaeb Center for Health Research, Tampa, FL 33647, USA
    Diabetes Technol Ther 7:675-80; discussion 681-3. 2005
    ..The objective of this study was to assess how the accuracy of the FreeStyle Flash (Abbott Diabetes Care, Alameda, CA) meter compares with that of the One Touch Ultra (Lifescan, Milpitas, CA) home glucose meter (HGM)...
  50. ncbi Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1
    Jay M Sosenko
    Division of Endocrinology, University of Miami, PO Box 016960 D110, Miami, FL 33101, USA
    Diabetes Care 29:643-9. 2006
    ..The goal of this study was to utilize data from the Diabetes Prevention Trial-Type 1 (DPT-1) to obtain a picture of the metabolic progression to type 1 diabetes over a period of approximately 2.5 years before its diagnosis...
  51. ncbi A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes
    H Peter Chase
    DirecNet Coordinating Center, Jaeb Center for Health Research, 15310 Amberly Drive, Suite 350, Tampa, FL 33647, USA
    Diabetes Care 28:1101-6. 2005
    ..This study assesses whether use of the GlucoWatch G2 Biographer (GW2B) in addition to standard glucose monitoring lowers HbA(1c) and reduces hypoglycemia compared with standard glucose monitoring alone...
  52. ncbi Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1
    Jay S Skyler
    University of Miami, PO Box 016960 D 110, Miami, FL 33101 6960, USA
    Diabetes Care 28:1068-76. 2005
    ..This randomized, double-masked, placebo-controlled clinical trial tested whether oral insulin administration could delay or prevent type 1 diabetes in nondiabetic relatives at risk for diabetes...
  53. ncbi Nocturnal hypoglycemia--an unrelenting problem
    H Peter Chase
    J Clin Endocrinol Metab 91:2038-9. 2006
  54. ncbi Treatment of adolescents with type 1 diabetes mellitus
    Satish Garg
    J Pediatr Endocrinol Metab 17:805-6. 2004
  55. ncbi Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1
    Jay M Sosenko
    Division of Endocrinology, University of Miami, P O Box 016960 D110, Miami, FL 33101, USA
    Diabetes Care 30:38-42. 2007
    ....
  56. ncbi Glycemic control in prepubertal years
    H Peter Chase
    Diabetes Care 26:1304-5. 2003
  57. ncbi Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: results of the Diabetes Research in Children Network (DirecNet) accuracy study
    Nelly Mauras
    DirecNet Coordinating Center, Tampa, Florida, USA
    J Pediatr 144:770-5. 2004
    ..CONCLUSIONS: Neither the CGMS nor the GW2B is accurate enough to establish population standards of the glycemic profile of healthy children and cannot be recommended in the workup of hypoglycemia in nondiabetic youth...
  58. ncbi Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator)
    Bruce Buckingham
    Pediatr Diabetes 9:142-7. 2008
    ..CONCLUSIONS: These results show the feasibility of implementing the DATA when real-time continuous glucose monitoring is initiated and support its use in future clinical trials of real-time continuous glucose monitoring...
  59. ncbi How should we interpret "real life" conditions
    Richard C Eastman
    Pediatr Diabetes 4:59. 2003

Research Grants2

  1. Glucose Sensors in Children with Type I Diabetes
    H Chase; Fiscal Year: 2006
    ..Quality of Life and Fear of Hypoglycemia Questionnaires will be used to evaluate psychological factors in both the factors in both the feasibility and the two-year trials. ..